A 52-week, randomized, double-blind, placebo-controlled, parallel-group, study to evaluate the efficacy and safety of two doses of CHF6001 DPI add-on to maintenance triple therapy in subjects with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Project: Research

HREC Reference Number: 2022/HRE00289
SSA Reference Number: SSA/94546/MonH-2023-370687(v1)
Monash Health Reference Number: RES-23-0000-278X

Status	Active
Effective start/end date	23/06/23 → 13/06/28

Project Details